A stepwise α-thalassemia screening strategy in high-prevalence areas

Salam S. Alkindi, Shoaib Alzadjali, Shahina Daar, Eunice Sindhuvi, Yasser Wali, Anil V. Pathare, Suresh Venugopal, Claudine Lapoumeroulie, Alok Srivastava, Rajagopal Krishnamoorthy

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction: Coinheritance of α-thalassemia influences the clinical and hematological phenotypes of β-hemoglobinopathies (β-thalassemia and sickle cell disease) and when present together in significant frequency within a population, a spectrum of clinical forms is observed. Precise molecular characterization of α-thalassemia is important in understanding their disease-modifying role in β-hemoglobinopathies and for diagnostic purposes. Patients and methods: Because currently used approaches are labor/cost-intensive, time-consuming, error-prone in certain genotype combinations and not applicable for large epidemiological screening, we developed a systematic stepwise strategy to overcome these difficulties. We successfully applied this to characterize the α-globin gene status in 150 Omani cord blood samples with Hb Barts and 32 patients with HbH disease. Results: We observed a good correlation between α-globin genotypes and level of Hb Bart's with the Hb Bart's levels significantly higher in both deletional and non-deletional α-globin genotypes. The most common α-globin genotype in HbH cases was αTSaudiα/αTSaudi α (n = 16; 50%) followed by -α3.7/-MED (n = 10; 31%). This approach detects also the α-globin gene triplication as exemplified by the study of a family where the β-globin gene defect failed to explain the β-thalassemia intermedia phenotype. Conclusion: Molecular characterization of α-thalassemia is complex due to high sequence homology between the duplicated α-globin genes and to the existence of a variety of gene rearrangements (small and large deletions of various sizes) and punctual substitutions (non-deletional alleles). The novelty of our strategy resides, not in the individual technical steps per se but in the reasoned sequential order of their use taking into consideration the hematological phenotype as well.

Original languageEnglish
Pages (from-to)164-169
Number of pages6
JournalEuropean Journal of Haematology
Volume91
Issue number2
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Thalassemia
Globins
Genotype
Hemoglobinopathies
Phenotype
Genes
Gene Rearrangement
beta-Thalassemia
Sickle Cell Anemia
Sequence Homology
Fetal Blood
Alleles
Costs and Cost Analysis
Population

Keywords

  • α-thalassemia
  • GeneScan
  • HbH
  • Newborn

ASJC Scopus subject areas

  • Hematology

Cite this

A stepwise α-thalassemia screening strategy in high-prevalence areas. / Alkindi, Salam S.; Alzadjali, Shoaib; Daar, Shahina; Sindhuvi, Eunice; Wali, Yasser; Pathare, Anil V.; Venugopal, Suresh; Lapoumeroulie, Claudine; Srivastava, Alok; Krishnamoorthy, Rajagopal.

In: European Journal of Haematology, Vol. 91, No. 2, 08.2013, p. 164-169.

Research output: Contribution to journalArticle

Alkindi, SS, Alzadjali, S, Daar, S, Sindhuvi, E, Wali, Y, Pathare, AV, Venugopal, S, Lapoumeroulie, C, Srivastava, A & Krishnamoorthy, R 2013, 'A stepwise α-thalassemia screening strategy in high-prevalence areas', European Journal of Haematology, vol. 91, no. 2, pp. 164-169. https://doi.org/10.1111/ejh.12136
Alkindi, Salam S. ; Alzadjali, Shoaib ; Daar, Shahina ; Sindhuvi, Eunice ; Wali, Yasser ; Pathare, Anil V. ; Venugopal, Suresh ; Lapoumeroulie, Claudine ; Srivastava, Alok ; Krishnamoorthy, Rajagopal. / A stepwise α-thalassemia screening strategy in high-prevalence areas. In: European Journal of Haematology. 2013 ; Vol. 91, No. 2. pp. 164-169.
@article{ec006d751cd34891a8c26c6a4b96f249,
title = "A stepwise α-thalassemia screening strategy in high-prevalence areas",
abstract = "Introduction: Coinheritance of α-thalassemia influences the clinical and hematological phenotypes of β-hemoglobinopathies (β-thalassemia and sickle cell disease) and when present together in significant frequency within a population, a spectrum of clinical forms is observed. Precise molecular characterization of α-thalassemia is important in understanding their disease-modifying role in β-hemoglobinopathies and for diagnostic purposes. Patients and methods: Because currently used approaches are labor/cost-intensive, time-consuming, error-prone in certain genotype combinations and not applicable for large epidemiological screening, we developed a systematic stepwise strategy to overcome these difficulties. We successfully applied this to characterize the α-globin gene status in 150 Omani cord blood samples with Hb Barts and 32 patients with HbH disease. Results: We observed a good correlation between α-globin genotypes and level of Hb Bart's with the Hb Bart's levels significantly higher in both deletional and non-deletional α-globin genotypes. The most common α-globin genotype in HbH cases was αTSaudiα/αTSaudi α (n = 16; 50{\%}) followed by -α3.7/-MED (n = 10; 31{\%}). This approach detects also the α-globin gene triplication as exemplified by the study of a family where the β-globin gene defect failed to explain the β-thalassemia intermedia phenotype. Conclusion: Molecular characterization of α-thalassemia is complex due to high sequence homology between the duplicated α-globin genes and to the existence of a variety of gene rearrangements (small and large deletions of various sizes) and punctual substitutions (non-deletional alleles). The novelty of our strategy resides, not in the individual technical steps per se but in the reasoned sequential order of their use taking into consideration the hematological phenotype as well.",
keywords = "α-thalassemia, GeneScan, HbH, Newborn",
author = "Alkindi, {Salam S.} and Shoaib Alzadjali and Shahina Daar and Eunice Sindhuvi and Yasser Wali and Pathare, {Anil V.} and Suresh Venugopal and Claudine Lapoumeroulie and Alok Srivastava and Rajagopal Krishnamoorthy",
year = "2013",
month = "8",
doi = "10.1111/ejh.12136",
language = "English",
volume = "91",
pages = "164--169",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - A stepwise α-thalassemia screening strategy in high-prevalence areas

AU - Alkindi, Salam S.

AU - Alzadjali, Shoaib

AU - Daar, Shahina

AU - Sindhuvi, Eunice

AU - Wali, Yasser

AU - Pathare, Anil V.

AU - Venugopal, Suresh

AU - Lapoumeroulie, Claudine

AU - Srivastava, Alok

AU - Krishnamoorthy, Rajagopal

PY - 2013/8

Y1 - 2013/8

N2 - Introduction: Coinheritance of α-thalassemia influences the clinical and hematological phenotypes of β-hemoglobinopathies (β-thalassemia and sickle cell disease) and when present together in significant frequency within a population, a spectrum of clinical forms is observed. Precise molecular characterization of α-thalassemia is important in understanding their disease-modifying role in β-hemoglobinopathies and for diagnostic purposes. Patients and methods: Because currently used approaches are labor/cost-intensive, time-consuming, error-prone in certain genotype combinations and not applicable for large epidemiological screening, we developed a systematic stepwise strategy to overcome these difficulties. We successfully applied this to characterize the α-globin gene status in 150 Omani cord blood samples with Hb Barts and 32 patients with HbH disease. Results: We observed a good correlation between α-globin genotypes and level of Hb Bart's with the Hb Bart's levels significantly higher in both deletional and non-deletional α-globin genotypes. The most common α-globin genotype in HbH cases was αTSaudiα/αTSaudi α (n = 16; 50%) followed by -α3.7/-MED (n = 10; 31%). This approach detects also the α-globin gene triplication as exemplified by the study of a family where the β-globin gene defect failed to explain the β-thalassemia intermedia phenotype. Conclusion: Molecular characterization of α-thalassemia is complex due to high sequence homology between the duplicated α-globin genes and to the existence of a variety of gene rearrangements (small and large deletions of various sizes) and punctual substitutions (non-deletional alleles). The novelty of our strategy resides, not in the individual technical steps per se but in the reasoned sequential order of their use taking into consideration the hematological phenotype as well.

AB - Introduction: Coinheritance of α-thalassemia influences the clinical and hematological phenotypes of β-hemoglobinopathies (β-thalassemia and sickle cell disease) and when present together in significant frequency within a population, a spectrum of clinical forms is observed. Precise molecular characterization of α-thalassemia is important in understanding their disease-modifying role in β-hemoglobinopathies and for diagnostic purposes. Patients and methods: Because currently used approaches are labor/cost-intensive, time-consuming, error-prone in certain genotype combinations and not applicable for large epidemiological screening, we developed a systematic stepwise strategy to overcome these difficulties. We successfully applied this to characterize the α-globin gene status in 150 Omani cord blood samples with Hb Barts and 32 patients with HbH disease. Results: We observed a good correlation between α-globin genotypes and level of Hb Bart's with the Hb Bart's levels significantly higher in both deletional and non-deletional α-globin genotypes. The most common α-globin genotype in HbH cases was αTSaudiα/αTSaudi α (n = 16; 50%) followed by -α3.7/-MED (n = 10; 31%). This approach detects also the α-globin gene triplication as exemplified by the study of a family where the β-globin gene defect failed to explain the β-thalassemia intermedia phenotype. Conclusion: Molecular characterization of α-thalassemia is complex due to high sequence homology between the duplicated α-globin genes and to the existence of a variety of gene rearrangements (small and large deletions of various sizes) and punctual substitutions (non-deletional alleles). The novelty of our strategy resides, not in the individual technical steps per se but in the reasoned sequential order of their use taking into consideration the hematological phenotype as well.

KW - α-thalassemia

KW - GeneScan

KW - HbH

KW - Newborn

UR - http://www.scopus.com/inward/record.url?scp=84880800158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880800158&partnerID=8YFLogxK

U2 - 10.1111/ejh.12136

DO - 10.1111/ejh.12136

M3 - Article

C2 - 23668236

AN - SCOPUS:84880800158

VL - 91

SP - 164

EP - 169

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 2

ER -